Clara Kim, Pharm.D. Email & Phone Number

Chapel Hill, Nc, Us

• Products: Rare Tumors (gilteritinib, zolbetuximab)

North Chicago, Illinois, Us

• Products supported: upadacitinib, risankizumab• Engaged in scientific discussions with KOL panel and respond to medical inquiries• Developed and managed priority KOL lists and customized engagement plans based on local/regional/national level of influence• Advanced focused, differentiated scientific narratives using patient-centric probing questions, assertive requests and strategic utilization of resources• Engaged in cross functional collaboration with sales team and headquarters-based medical affairs team

Basel, Switzerland, Ch

• Products supported: Tafinlar/Mekinist, tislelizumab• Acted as final reviewer for Tafinlar/Mekinist melanoma global guidance documents and provide timely responses to globally escalated inquiries • Led product information training to onboard new internal medical information team members• Participated in medical information excellence initiatives such as natural language processing-based medical information metrics generating platform to capture inquiry insights• Led quarterly MSL insights meetings to gain KOL insights and develop action items to implement educational strategies in collaboration with cross-functional colleagues• Generated quarterly key insight topics and questions for global oncology MSLs and country/region medical team members to assist in gathering field insights• Attended virtual congresses to collect insights for competitor trials and treatment landscape• Developed and managed priority KOL lists and customized engagement plans by incorporating insights from advisory boards, publication and congress involvement• Coordinated and executed disease state training for MSLs led by external medical experts • Led the development of the field medical section of a resource toolkit to improve global MSL team members' onboarding experience and assist key resource navigation

Basel, Switzerland, Ch

• Cross-trained on 29 oncology products and 78 product indications and pipeline products to respond to ~350 unsolicited inquiries from healthcare professionals• Authored and peer reviewed ~150 medical response documents and references• Participated in promotional review meetings as medical reviewer to evaluate oncology commercial materials alongside legal and regulatory colleagues• Provided oncology product education, encompassing product information and most frequently requested inquiries, to ~40 sales representatives and new hires• Prepared and submitted compendia submissions to inform errors and provided new publications forguideline consideration• Led onboarding for 5 new hires by preparing training schedule and conducting training for inquiry fulfillment and response document management process

New Brunswick, New Jersey, Us

Chapel Hill, North Carolina, Us

• Gynecologic Oncology Clinic, UNC Medical Center• Outpatient Pharmacy, UNC Hillsborough• Emergency Department, UNC Rex • Medication Use Policy and Analytics, UNC Medical Center• Neonatal Intensive Care Unit, UNC Rex

Melbourne, Vic, Au

Clinical rotation with neuroscience department at Alfred Hospital in Melbourne, Australia.

Lawrence Township, Nj, Us

• Led commercial opportunity assessment project for pipeline product to recommend viability of potential target patient population• Engaged in market research through assessing HCP interviews, conducting a gap analysis and analyzing competitive landscape• Developed preliminary forecasting model utilizing research on disease state epidemiology, treatment rates and predicted market share

Chapel Hill, Nc, Us

• Served as founding member and student lead for a global partnership organization with pharmacy schools at University College of London (UK), and Monash University (AUS) to share innovative global pharmacy initiatives • Created standard operating procedures document for student leaders across three countries• Managed project committees: Medication Safety, Interschool Communications, and International Case Competition

Chapel Hill, Nc, Us

Impact of a pharmacogenomics educational intervention utilizing a next-generation sequencing platform on future pharmacistsPI: Dr. Amber Frick, Pharm.D., Ph.D.

Nashville, Tennessee, Us

Integrin aVb3 biological activity by novel cRGD peptidomimetic drugs and aVb3 mediated modulation of SERT in vivo and in vitroDepartment of Pharmacology, Ana Carneiro Lab

Doctor Of Pharmacy (Pharm.D.), Pharmacy

Bachelor Of Arts (B.A.), Neuroscience